logo
Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market

Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market

Business Upturn4 hours ago
By Aman Shukla Published on July 1, 2025, 15:28 IST
Global pharma leader Lupin Limited has announced a major strategic shift by carving out its consumer healthcare arm, LupinLife Consumer Healthcare Ltd. (LCH), into a wholly owned subsidiary, effective today. The move is aimed at creating a focused, agile entity to tap into India's fast-evolving self-care and over-the-counter (OTC) health product space.
LupinLife, launched in 2017, has built a strong footprint in the OTC segment with a science-backed product portfolio that includes well-known brands like Softovac®, Beplex Forte®, Corcium®, and Aptivate®. With this restructuring, Lupin is doubling down on its ambitions to strengthen consumer health offerings and deepen its reach in one of the world's most dynamic wellness markets.
The newly carved-out company will be led by Anil Kaushal, who steps in as Chief Executive Officer. Under his leadership, the focus will be on unlocking new growth opportunities, expanding market presence, and scaling investments to drive stronger consumer connect and innovation.
Nilesh Gupta, Managing Director, Lupin, stated, 'This strategic move reinforces our mission of developing high-impact businesses that drive sustained value. LCH exemplifies our unwavering dedication to patient-centric care and service to consumers.'
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Maruti Suzuki India posts 6% YoY decline in total sales for June 2025; Export performance at all-time monthly high
Maruti Suzuki India posts 6% YoY decline in total sales for June 2025; Export performance at all-time monthly high

Business Upturn

time3 hours ago

  • Business Upturn

Maruti Suzuki India posts 6% YoY decline in total sales for June 2025; Export performance at all-time monthly high

By Aman Shukla Published on July 1, 2025, 16:28 IST Maruti Suzuki India reported a 6% drop in total sales for June 2025, selling 167,993 units compared to 179,228 units in the same month last year. The decline was largely driven by weaker domestic demand, although the company recorded its highest-ever monthly exports. In the domestic market, Maruti sold 121,339 vehicles in June, including 2,433 units of its light commercial vehicle, Super Carry. Passenger vehicle sales stood at 118,906 units, down from 137,160 units in June 2024. Sales of mini and compact cars — which include popular models like the Alto, WagonR, and Baleno — fell sharply, dropping to 60,591 units from 73,444 a year earlier. The mid-size sedan Ciaz also saw muted numbers, with just over 1,000 units sold. Utility vehicles, a category that includes models like the Brezza, Ertiga, and Grand Vitara, contributed 47,947 units to the monthly tally, slightly lower than last year. Meanwhile, van sales, primarily led by the Eeco, also slipped year-on-year. On a more positive note, Maruti's exports touched 37,842 units in June — the highest monthly number ever for the company. Sales to other original equipment manufacturers (OEMs) came in at 8,812 units. Looking at the broader April-June quarter, Maruti's total sales stood at 527,861 units, marginally up from 521,868 units in the same period last year. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Nibe bags Rs 22.66 crore order for the supply of Turret Structure Assemblies
Nibe bags Rs 22.66 crore order for the supply of Turret Structure Assemblies

Business Upturn

time3 hours ago

  • Business Upturn

Nibe bags Rs 22.66 crore order for the supply of Turret Structure Assemblies

Nibe Ltd. has secured a significant purchase order valued at ₹22.66 crore from one of India's leading infrastructure and defence companies. The contract involves the supply of Turret Structure Assemblies, a critical component used in defence equipment manufacturing. The order is domestic in nature and will be fulfilled in phases, with completion expected by June 28, 2026. The total contract value includes all applicable taxes and duties. In the exchange filing, the Nibe shared, 'The company has received a Purchase Order from one of the leading Infra and Defence Company for Supply of Turrets Structure Assembly for a total consideration of Rs. 22.66 Crores (inclusive of all taxes and duties) as per details mentioned in annexure A.' This latest win highlights Nibe's growing presence in the defence manufacturing sector and reinforces its role as a reliable supplier of high-precision structural assemblies for the country's defence infrastructure. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market
Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market

Business Upturn

time4 hours ago

  • Business Upturn

Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus on OTC consumer wellness market

By Aman Shukla Published on July 1, 2025, 15:28 IST Global pharma leader Lupin Limited has announced a major strategic shift by carving out its consumer healthcare arm, LupinLife Consumer Healthcare Ltd. (LCH), into a wholly owned subsidiary, effective today. The move is aimed at creating a focused, agile entity to tap into India's fast-evolving self-care and over-the-counter (OTC) health product space. LupinLife, launched in 2017, has built a strong footprint in the OTC segment with a science-backed product portfolio that includes well-known brands like Softovac®, Beplex Forte®, Corcium®, and Aptivate®. With this restructuring, Lupin is doubling down on its ambitions to strengthen consumer health offerings and deepen its reach in one of the world's most dynamic wellness markets. The newly carved-out company will be led by Anil Kaushal, who steps in as Chief Executive Officer. Under his leadership, the focus will be on unlocking new growth opportunities, expanding market presence, and scaling investments to drive stronger consumer connect and innovation. Nilesh Gupta, Managing Director, Lupin, stated, 'This strategic move reinforces our mission of developing high-impact businesses that drive sustained value. LCH exemplifies our unwavering dedication to patient-centric care and service to consumers.' Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store